HR+/HER2- breast cancer can be classified into four main molecular subtypes using gene expression profiling (PAM50) (i.e., Luminal A, Luminal B, HER2-enriched, and Basal-like)12. The gene discussed is ERBB2; the disease is breast carcinoma.